Insights

AI driven health Sema4 leverages AI and machine learning on multidimensional clinical and genomic data to build dynamic health trajectories, presenting a sales opportunity to offer advanced data integration, analytics, and decision-support solutions to biopharma, payers, and healthcare providers seeking personalized care insights.

Enterprise AI expansion Recent GA of a full stack AI agent platform signals a pivot toward enterprise-facing AI capabilities, suggesting potential upsell of AI agent services, workflow automation, and knowledge work acceleration tools to large healthcare organizations and life sciences customers.

Healthcare data platform Centrellis, Sema4’s health intelligence platform, positions the company as a data-and-insights partner; opportunities exist to provide data governance, interoperability, and secure data sharing solutions to institutions aiming to derive actionable clinical and genomic insights.

Strategic partnerships With a focus on patient-centered insights and data sharing for collective benefit, there is potential to pursue collaborations with hospitals, research networks, and biotech firms to co-develop predictive models and population health initiatives.

Growth and visibility Notable recognition in Gartner hype cycles and press coverage, combined with mid-market revenue, indicates momentum and credibility to approach mid-to-large healthcare systems and biotech companies seeking innovative AI-driven health intelligence capabilities.

Sema4 Tech Stack

Sema4 uses 6 technology products and services including Amazon Web Services, Bitly, Lever, and more. Explore Sema4's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Bitly
    Marketing
  • Lever
    Recruitment Marketing
  • Google
    Search Engines
  • Zoom
    Web Conferencing
  • Google Hangouts
    Web Conferencing

Media & News

Sema4's Email Address Formats

Sema4 uses at least 2 format(s):
Sema4 Email FormatsExamplePercentage
First.Last@sema4.comJohn.Doe@sema4.com
98%
First.Middle@sema4.comJohn.Michael@sema4.com
2%
First.Last@sema4genomics.comJohn.Doe@sema4genomics.com
98%
LastFirst@sema4genomics.comDoeJohn@sema4genomics.com
1%
LF@sema4genomics.comDJ@sema4genomics.com
1%

Frequently Asked Questions

What is Sema4's stock symbol?

Minus sign iconPlus sign icon
Sema4 is a publicly traded company; the company's stock symbol is SMFR.

How much revenue does Sema4 generate?

Minus sign iconPlus sign icon
As of July 2026, Sema4's annual revenue is estimated to be $50M - $100M.

What is Sema4's SIC code NAICS code?

Minus sign iconPlus sign icon
Sema4's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sema4 have currently?

Minus sign iconPlus sign icon
As of July 2026, Sema4 has approximately 141 employees across 6 continents, including North AmericaEuropeAfrica. Key team members include Cso: L. H.Chief Operating Officer: J. M.Chief Business Officer: K. S.. Explore Sema4's employee directory with LeadIQ.

What industry does Sema4 belong to?

Minus sign iconPlus sign icon
Sema4 operates in the Biotechnology Research industry.

What technology does Sema4 use?

Minus sign iconPlus sign icon
Sema4's tech stack includes Amazon Web ServicesBitlyLeverGoogleZoomGoogle Hangouts.

What is Sema4's email format?

Minus sign iconPlus sign icon
Sema4's email format typically follows the pattern of First.Last@sema4.com. Find more Sema4 email formats with LeadIQ.

When was Sema4 founded?

Minus sign iconPlus sign icon
Sema4 was founded in 2017.
Sema4 logo

Sema4

Biotechnology ResearchConnecticut, United States51-200 Employees

Sema4 is a biotechnology research company based in Stamford, Connecticut. It focuses on patient-centered health intelligence, applying artificial intelligence and machine learning to longitudinal clinical and genomic data to build dynamic models of health and individualized health trajectories. The company’s Centrellis health intelligence platform supports a more complete understanding of disease and wellness and informs science-driven solutions to pressing medical needs.

Operating at the intersection of biotechnology and data science, Sema4 aims to advance healthcare through data-driven insights while treating patients as partners and endorsing data sharing for the benefit of all. A notable recent development is the November 2024 announcement of the general availability of a full-stack AI agent platform from Sema4.ai, reflecting an expansion of its AI capabilities for enterprise work.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SMFR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $50M - $100M

    Sema4's revenue is estimated to be in the range of $50M - $100M

Section iconFunding & Financials

  • $50M - $100M

    Sema4's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.